Atilla, E. Et Al. 2017. HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients. 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , (Marseille, France).

Atilla, E., Dalva, K., Atilla, P. A., TOPRAK, S. K., Topcuoglu, P., Gulbas, Z., ... Arat, M.(2017). HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients . 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, France

Atilla, E. Et Al. "HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients," 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), Marseille, France, 2017

Atilla, E. Et Al. "HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients." 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Marseille, France, 2017

Atilla, E. Et Al. (2017) . "HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients." 43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) , Marseille, France.

@conferencepaper{conferencepaper, author={E. Atilla Et Al. }, title={HLA C1/C1 homozygosity decreases relapse rate after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in acute myeloid leukemia (AML) patients}, congress name={43rd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT)}, city={Marseille}, country={France}, year={2017}}